secwatch / observer
8-K filed March 2, 2023, 6:59 PM ET ticker KR CIK 0000056873
earnings confidence high sentiment positive materiality 0.75

Kroger Q4 identical sales +6.2%, adj EPS $0.99; FY23 guidance $4.45-$4.60

KROGER CO

2022-FY EPS reported $3.06 revenue$148,258,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

KROGER CO reported fiscal year 2022 results: revenue $148.3 billion, EPS $ 3.06.

Period
fiscal year 2022
Revenue
$148.3 billion
EPS
$ 3.06
Result
reported results
Exact text from the filing
EPS $ 3.06 $ 2.17 Adjusted EPS (Table 6) $ 4.23 $ 3.68 Operating Profit $ 4.1 $ 3.5 Adjusted FIFO Operating Profit (Table 7) $ 5.1 $ 4.3 FIFO Gross Margin Rate* Decreased 9 basis points OG&A Rate* Decreased 19 basis points * Without fuel and adjustment items, if applicable. Identical sales without fuel would have grown 5.8% in Fiscal 2022 if not for the reduction in pharmacy sales from Kroger’s termination of its agreement with Express Scripts effective December 31, 2022. This terminated agreement had no material impact on profitability. 3 Total company sales were $148.3 billion in 2022, compared to $137.9 billion for the same period last year.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

KROGER CO reported fourth quarter 2022 results: revenue $34.8 billion, EPS $ 0.62.

Period
fourth quarter 2022
Revenue
$34.8 billion
EPS
$ 0.62
Result
reported results
Exact text from the filing
EPS** $ 0.62 $ 0.75 Adjusted EPS (Table 6) $ 0.99 $ 0.91 Operating Profit** $ 826 $ 965 Adjusted FIFO Operating Profit (Table 7) $ 1,274 $ 1,014 FIFO Gross Margin Rate* Decreased 1 basis point OG&A Rate* Decreased 56 basis points * Without fuel and adjustment items, if applicable. Identical sales without fuel would have grown 6.7% in the 4th quarter if not for the reduction in pharmacy sales from Kroger’s termination of its agreement with Express Scripts effective December 31, 2022. This terminated agreement had no material impact on profitability. ** Included in our EPS and Operating Profit this quarter was a $164 million goodwill and fixed asset impairment charge relating to Vitacost.com and $160 million charge for the fair value of interest rate hedges associated with proposed merger financing. 2 Total company sales were $34.8 billion in the fourth quarter, compared to $33.0 billion for the same period last year.
View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

KROGER CO filing history →

Source: SEC EDGAR
accession 0001104659-23-027695
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.